药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Bacampicillin
Sitafloxacin
Zinc sulfate, unspecified form can cause a decrease in the absorption of Sitafloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Bacampicillin
Prulifloxacin
Zinc sulfate, unspecified form can cause a decrease in the absorption of Prulifloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Bacampicillin
Pazufloxacin
Zinc sulfate, unspecified form can cause a decrease in the absorption of Pazufloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Bacampicillin
Difloxacin
Zinc sulfate, unspecified form can cause a decrease in the absorption of Difloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Bacampicillin
Sarafloxacin
Zinc sulfate, unspecified form can cause a decrease in the absorption of Sarafloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Bacampicillin
Orbifloxacin
Zinc sulfate, unspecified form can cause a decrease in the absorption of Orbifloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Bacampicillin
Enrofloxacin
Zinc sulfate, unspecified form can cause a decrease in the absorption of Enrofloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Bacampicillin
Flumequine
Zinc sulfate, unspecified form can cause a decrease in the absorption of Flumequine resulting in a reduced serum concentration and potentially a decrease in efficacy.
Bacampicillin
Nemonoxacin
Zinc sulfate, unspecified form can cause a decrease in the absorption of Nemonoxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Bacampicillin
Garenoxacin
Zinc sulfate, unspecified form can cause a decrease in the absorption of Garenoxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Bacampicillin
Technetium Tc-99m ciprofloxacin
Zinc sulfate, unspecified form can cause a decrease in the absorption of Technetium Tc-99m ciprofloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Bacampicillin
Fleroxacin
Zinc sulfate, unspecified form can cause a decrease in the absorption of Fleroxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Bacampicillin
Deferasirox
Zinc sulfate, unspecified form can cause a decrease in the absorption of Deferasirox resulting in a reduced serum concentration and potentially a decrease in efficacy.
Bacampicillin
Deferiprone
Zinc sulfate, unspecified form can cause a decrease in the absorption of Deferiprone resulting in a reduced serum concentration and potentially a decrease in efficacy.
Bacampicillin
Raltegravir
Zinc sulfate, unspecified form can cause a decrease in the absorption of Raltegravir resulting in a reduced serum concentration and potentially a decrease in efficacy.
Tiaprofenic acid
Satralizumab
The serum concentration of Hydrocortisone valerate can be decreased when it is combined with Satralizumab.
Tiaprofenic acid
Oliceridine
The serum concentration of Oliceridine can be decreased when it is combined with Hydrocortisone valerate.
Tiaprofenic acid
Abametapir
The serum concentration of Hydrocortisone valerate can be increased when it is combined with Abametapir.
Tiaprofenic acid
Inebilizumab
The risk or severity of infection can be increased when Hydrocortisone valerate is combined with Inebilizumab.
Tiaprofenic acid
Selpercatinib
The serum concentration of Selpercatinib can be decreased when it is combined with Hydrocortisone valerate.